Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Veteran investment professional focused on growth equity and operational value creation across technology and healthcare, with experience sourcing deals, leading follow-on rounds and partnering with founders to scale revenue and margins. Debbie Fox combines operating leadership and investor diligence, with a background in corporate strategy, portfolio operations and fund-level governance.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
Focuses on growth equity investments in technology and healthcare, prioritizing scalable business models where operational improvements can unlock margin expansion and revenue acceleration. Emphasizes founder alignment, disciplined follow-on capital allocation, and rigorous diligence that blends corporate-strategy thinking with hands-on portfolio operations. Seeks companies with clear go-to-market leverage, durable unit economics, and pathways to market leadership where active governance and KPI-driven operational interventions drive value. Time horizon is growth-stage multi-year scaling rather than short-term exits; risk management centers on staging capital, milestone-based value creation plans, and close operator-investor collaboration.
| Trades 957 | Longs Won 647/957 67% | Profit Factor 6.79 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $382,285.37 |
| Average Win $123,072.97 | Best Trade (Aug 05) $6.35M | Sharpe Ratio -9.5 |
| Average Loss -$37,846.32 | Worst Trade (Aug 02) -$1.34M | Z-Score 8.89 (100%) |
| Commissions $0 | Avg. Trade Length 10m 3w 2d | Expectancy $70,946.55 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,264 | 7,438 | 6,612 | 5,785 | 4,959 | 4,132 | 3,306 | 2,479 | 1,653 | 826 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 64,214 | $16.08M | $19.84M | - | $3.76M | 23.36% | -7.354% |
ABBNY ABB Ltd. Sponsored ADR | 2,300 | $249,717 | $226,826 | - | -$22,891 | -9.17% | +0.397% |
ABBV AbbVie Inc. | 5,258 | $1.05M | $1.32M | - | $264,731.41 | 25.1% | -2.513% |
ABT Abbott Laboratories | 18,978 | $2.17M | $2.01M | - | -$168,665.58 | -7.76% | +0.085% |
ACN Accenture plc Class A | 11,706 | $3.2M | $1.94M | - | -$1.26M | -39.32% | +1.611% |
ADBE Adobe Inc. | 1,186 | $499,771.27 | $296,986.26 | - | -$202,785.01 | -40.58% | +1.013% |
ADI Analog Devices, Inc. | 10,398 | $2.26M | $3.82M | - | $1.56M | 68.92% | +0.202% |
ADP Automatic Data Processing Inc. | 1,314 | $372,497.08 | $350,128.43 | - | -$22,368.65 | -6.01% | +0.982% |
ADSK Autodesk, Inc. | 4,129 | $885,073.48 | $967,011.8 | - | $81,938.32 | 9.26% | -0.328% |
AEP American Electric Power Company, Inc. | 1,500 | $205,215 | $191,775 | - | -$13,440 | -6.55% | +0.055% |
AFL Aflac Inc. | 6,531 | $675,566.8 | $832,571.88 | - | $157,005.08 | 23.24% | +0.094% |
AJG Arthur J. Gallagher & Co. | 1,050 | $291,316 | $261,891 | - | -$29,425 | -10.1% | -2.745% |
ALC Alcon Inc. | 4,874 | $412,609.51 | $336,013.56 | - | -$76,595.95 | -18.56% | -0.963% |
ALL Allstate Corporation | 3,270 | $630,423.44 | $863,541.56 | - | $233,118.12 | 36.98% | -0.49% |
AMAT Applied Materials, Inc. | 12,036 | $2.28M | $6.11M | - | $3.83M | 168.16% | +1.176% |
AMD Advanced Micro Devices, Inc. | 9,023 | $1.82M | $4.3M | - | $2.47M | 135.81% | -1.904% |
AMGN Amgen Inc. | 1,979 | $592,246.25 | $762,231.64 | - | $169,985.39 | 28.7% | -0.64% |
AMLP Alerian MLP ETF | 12,064 | $631,217.34 | $667,380.48 | - | $36,163.14 | 5.73% | +0.894% |
AMT American Tower Corporation | 1,314 | $272,313.64 | $227,795.04 | - | -$44,518.6 | -16.35% | -0.631% |
AMZN Amazon.com Inc | 21,157 | $4.64M | $5.75M | - | $1.11M | 23.94% | +15.321% |